Shares of Cronos Group Inc. CRON shed 1.65% to $1.79 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.52% to 17, ...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today ...

(RTTNews) - Cannabinoid company Cronos Group, Inc. (CRON, CRON.TO) announced Wednesday the appointment of Anna Shlimak as Chief Financial Officer, effective today. Shlimak will succeed James Holm ...

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

If you've found yourself pondering the time-travel terrors teased in Bloober Team's Cronos: The New Dawn reveal ...

Cronos Group Inc. shares T.CRON are trading up $0.01 at $2.66.

Cronos Group Inc. (NASDAQ:CRON), a medicinal chemicals and botanical products company with a market capitalization of $707 million, announced significant executive changes today. According to ...

TORONTO - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), a global cannabinoid company with a market capitalization of $707 million, today announced the appointment of Anna Shlimak as its new Chief ...

Cronos Group Inc. closed 42.04% short of its 52-week high of $3.14, which the company achieved on May 16th.

Cronos Group (CRON)announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Shlimak, who previously served as ...

TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the ...